May 7 |
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
|
May 2 |
Mustang Bio Announces Closing of $4 Million Public Offering
|
May 1 |
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
|
Apr 30 |
Mustang Bio Announces Pricing of $4 Million Public Offering
|
Apr 29 |
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
|
Apr 25 |
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
|
Apr 24 |
Avenue Therapeutics Announces Reverse Stock Split
|
Apr 11 |
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
|
Mar 28 |
Fortress Biotech GAAP EPS of -$8.47 beats by $0.64, revenue of $84.51M beats by $4.83M
|
Mar 28 |
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
|